Healthcare Distribution Alliance – Patients Move Us.
Share Print
banner capitol

Issues

COVID-19 Response

HDA and its primary pharmaceutical distributor members are closely monitoring the ongoing situation around the novel COVID-19 coronavirus.

Distributors are working to anticipate and prevent disruptions to the supply chain and to ensure that pharmacies, hospitals, providers and, ultimately, their patients have access to the medicines and supplies they need. Sitting at the heart of the pharmaceutical supply chain, HDA’s distributor members are working closely with federal and state health officials to facilitate timely information sharing and coordination while also maintaining active business continuity plans in the event of disruptions to operations due to the pandemic.

HDA and our members will continue to engage as the situation evolves and this page will update as additional information from the healthcare and public health communities is made available.

Resources

CONTACT

  • Perry L. Fri
  • Executive Vice President, Industry Relations, Membership and Education, HDA; and Chief Operating Officer, HDA Research Foundation
  • (703) 885-0222
  • pfri@hda.org
  • John E. Parker
  • Senior Vice President, Communications
  • (703) 885-0216
  • jparker@hda.org
  • Anita T. Ducca
  • Senior Vice President, Regulatory Affairs
  • (703) 885-0240
  • aducca@hda.org
  • Matthew J. DiLoreto
  • Vice President, State Government Affairs
  • (703) 885-0236
  • mdiloreto@hda.org
  • Jewelyn A. Cosgrove
  • Director, Federal Government Affairs
  • (703) 885-0272
  • jcosgrove@hda.org
Website design and development by Americaneagle.com, inc
© 2018 Healthcare Distribution Alliance. All rights reserved.
HDA: E | C | C2 | NF | O365